Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company develops improved formulations of known molecules using drug delivery technologies. The Company is engaged in clinical and regulatory affairs, product licensing, supply chain management, and marketing and sales. The Company has three commercial products and a fourth in development. Its products include Absorica/Epuris, Lipofen and ConZi/Durela. The Company is focused on growth through new products, additional out-licensing agreements.